Table 1.
Cell type | Expression of VEC markers | Expression of VSMC markers | Expression of cardiomyocyte markers | Production of paracrine factors | Ref. |
Human fADSCs | CD31, vWF | NE | NE | NE | Miranville et al[30] |
Human cADSCs | CD31, vWF | NE | NE | NE | Planat-Benard et al[31] |
Human cADSCs | NE | SMA, calponin, caldesmon, myosin heavy chain, SM22α | NE | NE | Rodríguez et al[32] |
Human cADSCs | NE | SMA, calponin, SM22α | NE | NE | Jeon et al[33] |
Rabbit cADSCs | NE | NE | Myosin heavy chain, sarcomeric α-actinin, troponin I | NE | Rangappa et al[34] |
Human cADSCs | NE | NE | Sarcomeric α-actinin, desmin, cardiac troponin | NE | Gaustad et al[35] |
Murine fADSCs | NE | NE | GATA-4, Nkx2.5 | NE | Planat-Bénard et al[36] |
Human cADSCs | NE | NE | NE | VEGF, HGF, TGF-β | Rehman et al[44] |
Murine cADSCs | ND | ND | NE | VEGF, HGF | Nakagami et al[45] |
Human cADSCs | NE | NE | NE | VEGF, IGF-1 | Sadat et al[46] |
NE: Not examined; ND: Not detected; ADSCs: Adipose tissue-derived stem cells; VEC: Vascular endothelial cell; TGF: Transforming growth factor; VSMC: Vascular smooth muscle cell; HGF: Hepatocyte growth factor; IGF-1: Insulin-like growth factor-1; vWF: von Willebrand factor.